TF and prostate carcinoma: Synergy predictions for the prostate carcinoma cell line DU145 were consistently of moderate accuracy (AUC values ∼0.6–0.7), while predictions for the melanoma cell line (UACC62) was consistently the poorest, with an AUC value lower than 0.5 for the TF activity training data set.